Private Equity

With the hire of Patrick Duffy, Dropzone AI signals a major push in its mission to solve cybersecurity's twin crises with a new breed of AI agents.

A new partnership embeds PitchBook's data into Samaya AI, promising auditable insights for finance. Is this the answer to the AI 'black box' problem?

As AI-driven attacks escalate, BreachRx adds Phil Venables to its board, signaling a critical shift in how enterprises must manage cyber crises.

As AI pushes data centers to their limits, Divcon is betting on new leaders and a 'Grid-to-Chip' vision. Here's why its overhaul is critical for digital infrastructure.

After a disastrous failure, Stephenville's airport has a new owner. BTG Capital's acquisition is more than a local rescue; it's a play on global trade and defence.

Oxford Financial Group's major Cincinnati expansion highlights a national trend: the strategic battle for top talent and regional dominance in wealth management.

With a $5.3 billion backlog and pipeline, Congruex brings in financial heavyweight Jim Stanley to navigate explosive growth and complex market pressures.

Adial Pharmaceuticals pivots from addiction to inflammation, securing $32M and poaching Azora's leadership to drive its new ulcerative colitis drug, AT177.

Innovate 32's partnership with Viridian Dental Partners signals a new wave of consolidation in dentistry, backed by Shore Capital's deep private equity pockets.

New research reveals a stark divide: leaders prioritize R&D while the public and investors demand reinvestment in workers. Who will win the battle for AI's gains?

With a third consecutive GigaOm Leader nod, Scale Computing isn't just innovating; it's defining the future of distributed enterprise IT. What's their secret?

Tiny biotech HCW Biologics reports promising early data for its alopecia drug. But with a small sample size and big pharma rivals, is this a true breakthrough?

With $10M in funding, Magnitude launches an autonomous AI workforce to combat machine-speed threats, forcing a reckoning in third-party risk management.

J.D. Sitton's move to National signals a broader industry trend: the critical role of veteran IR leaders in navigating a complex real estate market.

A strategic investment in RCM provider Fellow Health Partners reveals a deeper trend: PE firms are now backing high-touch service, not just scalable tech.

ZRG's strategic acquisition of Fortium isn't just M&A; it's a major bet on the future of work, where on-demand CIOs and CISOs are the new normal.

Amid GBTG's strong growth and AI push, a law firm's probe into its $9.50/share buyout questions if shareholders are getting a fair deal.

With a major debt financing, French biotech Inventiva is funded through a pivotal Phase 3 trial for its MASH drug, highlighting a strategic shift in biotech funding.

A local firm wins its community's top award for the eighth time. We look past the trophy to analyze the blend of fiduciary focus and national growth driving its success.

With a historic $1.1B in funding, David Silver's Ineffable Intelligence partners with Google Cloud to build an AI that learns from experience, not just data.